CLEARPOINT NEURO INC's ticker is CLPT and the CUSIP is 18507C103. A total of 29 filers reported holding CLEARPOINT NEURO INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $950,657 | -32.4% | 189,752 | -2.2% | 0.00% | – |
| Q2 2023 | $1,405,291 | +325.3% | 194,101 | +395.8% | 0.00% | – |
| Q1 2023 | $330,418 | +11.1% | 39,149 | +11.5% | 0.00% | – |
| Q4 2022 | $297,356 | -18.3% | 35,107 | 0.0% | 0.00% | – |
| Q3 2022 | $364,000 | -9.9% | 35,107 | +13.2% | 0.00% | – |
| Q2 2022 | $404,000 | -76.3% | 31,001 | -81.1% | 0.00% | – |
| Q1 2022 | $1,703,000 | -10.8% | 163,600 | -3.8% | 0.00% | – |
| Q4 2021 | $1,909,000 | -35.9% | 170,143 | +1.5% | 0.00% | -100.0% |
| Q3 2021 | $2,976,000 | -11.6% | 167,655 | -5.0% | 0.00% | 0.0% |
| Q2 2021 | $3,368,000 | +478.7% | 176,426 | +541.0% | 0.00% | – |
| Q1 2021 | $582,000 | +74.3% | 27,522 | +30.9% | 0.00% | – |
| Q4 2020 | $334,000 | +447.5% | 21,018 | +88.2% | 0.00% | – |
| Q3 2020 | $61,000 | +56.4% | 11,166 | +1.0% | 0.00% | – |
| Q2 2020 | $39,000 | -2.5% | 11,053 | 0.0% | 0.00% | – |
| Q1 2020 | $40,000 | – | 11,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 47,148 | $168,000 | 0.16% |
| Worth Venture Partners, LLC | 76,361 | $272,000 | 0.13% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 151,584 | $539,000 | 0.06% |
| KIRR MARBACH & CO LLC /IN/ | 42,200 | $150,000 | 0.05% |
| Merriman Wealth Management, LLC | 47,690 | $170,000 | 0.03% |
| Parkman Healthcare Partners LLC | 25,078 | $89,000 | 0.02% |
| WESTWOOD MANAGEMENT CORP /IL/ | 17,500 | $62,000 | 0.01% |
| IEQ CAPITAL, LLC | 20,000 | $71,000 | 0.01% |
| Moisand Fitzgerald Tamayo, LLC | 2,216 | $8,000 | 0.00% |
| Williams Jones Wealth Management, LLC. | 21,552 | $77,000 | 0.00% |